Suven Life Sciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May '26 May 28, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	72,470	35,035	24,730	21,742	10,570	13,484
Market Cap Growth	133.78%	41.67%	13.74%	105.69%	-21.61%	50.48%
Enterprise Value	67,456	32,460	23,067	19,870	10,468	13,313
Last Close Price	274.80	132.85	113.40	99.70	48.47	85.47
Forward PE	-	3.65	3.65	3.65	3.65	3.65
PS Ratio	1018.60	492.44	371.55	185.94	77.75	112.83
PB Ratio	12.25	5.92	22.48	8.05	2.82	14.03
P/TBV Ratio	12.26	5.93	22.52	8.06	2.82	14.06
PEG Ratio	-	0.13	0.13	0.13	0.13	0.13
EV/Sales Ratio	-	456.24	346.57	169.93	77.00	111.40
Debt / Equity Ratio	0.03	0.03	-	0.00	0.00	0.03
Net Debt / Equity Ratio	-0.85	-0.85	-0.55	-0.89	-0.60	-0.49
Net Debt / EBITDA Ratio	1.78	1.78	0.36	1.86	1.80	0.39
Net Debt / FCF Ratio	1.65	1.65	0.31	2.07	1.91	0.32
Asset Turnover	0.02	0.02	0.03	0.04	0.06	0.10
Inventory Turnover	-	-	1.59	2.30	27.66	9.10
Quick Ratio	16.94	16.94	2.62	18.01	21.03	7.13
Current Ratio	17.70	17.70	3.21	18.99	22.61	8.01
Return on Equity (ROE)	-78.80%	-78.80%	-84.60%	-32.56%	-50.17%	-119.51%
Return on Assets (ROA)	-47.75%	-47.75%	-50.94%	-24.91%	-33.21%	-66.72%
Return on Invested Capital (ROIC)	-457.77%	-379.34%	-423.40%	-149.73%	-133.77%	-218.87%
Return on Capital Employed (ROCE)	-48.90%	-48.90%	-153.30%	-49.50%	-35.00%	-126.60%
Earnings Yield	-3.81%	-7.89%	-6.50%	-4.83%	-11.19%	-9.05%
FCF Yield	-4.23%	-8.76%	-7.74%	-5.31%	-11.25%	-10.93%
Dividend Yield	-	-	-	-	-	1.17%
Buyback Yield / Dilution	-4.47%	-4.47%	-	-22.31%	-32.29%	-5.88%
Total Shareholder Return	-4.47%	-4.47%	-	-22.31%	-32.29%	-4.71%